Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients

Bibliographic Details
Main Authors:	Tarhini, Ahmad A., Lin, Yan, Zahoor, Haris, Shuai, Yongli, Butterfield, Lisa H., Ringquist, Steven, Gogas, Helen, Sander, Cindy, Lee, Sandra, Agarwala, Sanjiv S., Kirwood, John M.
Format:	Online
Language:	English
Published:	Public Library of Science 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508028/

Similar Items

Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
by: Tarhini, Ahmad A., et al.
Published: (2015)

Intralesional therapy for advanced melanoma: promise and limitation
by: Agarwala, Sanjiv S.
Published: (2015)

Tumor associated PD-L1 expression pattern in microscopically tumor positive sentinel lymph nodes in patients with melanoma
by: Tarhini, Ahmad A., et al.
Published: (2015)

Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
by: Tarhini, Ahmad A., et al.
Published: (2014)

The use of immunotherapy in the treatment of melanoma
by: Tala Achkar, et al.
Published: (2017-04-01)

Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial
by: Kamm, Christian P., et al.
Published: (2014)

Adjuvant Therapy: Melanoma
by: Davar, Diwakar, et al.
Published: (2011)

Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma
by: Janet Retseck, et al.
Published: (2018-07-01)

CD8+ T cell responses in metastatic melanoma patients receiving an adenovirally antigen engineered dendritic cell vaccine +/- IFN-α
by: Du, Samuel, et al.
Published: (2015)

Phenotypic and functional testing of circulating regulatory T cells in advanced melanoma patients treated with neoadjuvant ipilimumab
by: Retseck, Janet, et al.
Published: (2016)

Emergency Surgery for Metastatic Melanoma
by: Mantas, Dimitrios, et al.
Published: (2014)

Everolimus (RAD001) in the Treatment of Advanced Renal Cell Carcinoma: A Review
by: Agarwala, Sanjiv S., et al.
Published: (2010)

A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon
by: Wang, Ena, et al.
Published: (2012)

Intravenous high‐dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta‐analysis of three trials
by: Malczewski, Agnieszka, et al.
Published: (2015)

A four-marker signature of TNF-RII, TGF-α, TIMP-1 and CRP is prognostic of worse survival in high-risk surgically resected melanoma
by: Tarhini, Ahmad A, et al.
Published: (2014)

Regression of nevi in a melanoma patient treated with interferon
by: Rishpon, Ayelet, et al.
Published: (2012)

Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
by: Paolicelli, Damiano, et al.
Published: (2009)

Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
by: Jankovic, Slobodan M
Published: (2010)

Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is There an Odd One Out?
by: Clapin, Alexis
Published: (2012)

Profile of PEGylated interferon beta in the treatment of relapsing-remitting multiple sclerosis
by: Cocco, Eleonora, et al.
Published: (2015)

The Impact of MS-Related Cognitive Fatigue on Future Brain Parenchymal Loss and Relapse: A 17-Month Follow-up Study
by: Sander, Carina, et al.
Published: (2016)

Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis
by: Kinyas, Şeref, et al.
Published: (2016)

Management of relapsing Plasmodium vivax malaria
by: Chu, Cindy S, et al.
Published: (2016)

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
by: Cohan, Stanley
Published: (2016)

Experimental Inoculation of Malaria, with a Relapse after Eight Months
by: Fearnside, C. F.
Published: (1903)

Internet-based relapse prevention for anorexia nervosa: nine- month follow-up
by: Fichter, Manfred Maximilian, et al.
Published: (2013)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
by: Wang, Sheng-Min, et al.
Published: (2014)

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma
by: Mozzillo, Nicola, et al.
Published: (2014)

Melanoma associated with congenital intermediate common blue nevus of the scalp - Case report*
by: Ribeiro, Camila Sampaio, et al.
Published: (2016)

A New Mathematical Model for the Interpretation of Translational Research Evaluating Six CTLA-4 Polymorphisms in High-Risk Melanoma Patients Receiving Adjuvant Interferon
by: Pancoska, Petr, et al.
Published: (2014)

Induction of the pro-myelocytic leukaemia gene by type I and type II interferons.
by: Heuser, M, et al.
Published: (1998)

Regulated intratumoral expression of IL-12 as a basis for combination therapy in melanoma
by: Nemunaitis, John J, et al.
Published: (2014)

Long-term pegylated interferon-α and its potential in the treatment of melanoma
by: Dummer, Reinhard, et al.
Published: (2009)

Down-Regulation of the Interferon Signaling Pathway in T Lymphocytes from Patients with Metastatic Melanoma
by: Critchley-Thorne, Rebecca J, et al.
Published: (2007)

Adjuvant therapy for melanoma: How should we respond to high-dose interferon?
by: de Takats, P. G., et al.
Published: (1998)

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
by: Håkansson, A., et al.
Published: (1996)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
by: Lenci, Romina Elizabeth, et al.
Published: (2012)

Recurrent Pericarditis, an Unexpected Effect of Adjuvant Interferon Chemotherapy for Malignant Melanoma
by: Ashraf, Farhan, et al.
Published: (2016)

Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells
by: Pisano, Marina, et al.
Published: (2007)

Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma
by: Nallet-Staub, Flore, et al.
Published: (2014)